In Brief: Novartis Clozaril
Executive Summary
Novartis Clozaril: Proposal to reduce frequency of white blood cell count monitoring for clozapine patients to be considered by FDA's Psychopharmacologic Drugs Advisory Committee July 14, starting at 8:30 a.m. at the Holiday Inn in Gaithersburg, Md...